Index S&P 500
P/E -
EPS (ttm) -10.24
Insider Own 17.72%
Shs Outstand 863.49M
Perf Week -1.16%
Market Cap 9.60B
Forward P/E 7.41
EPS next Y 1.50
Insider Trans 0.00%
Shs Float 711.51M
Perf Month 5.61%
Income -8834.00M
PEG -
EPS next Q 0.53
Inst Own 63.13%
Short Float 8.85%
Perf Quarter 11.33%
Sales 150.41B
P/S 0.06
EPS this Y -43.76%
Inst Trans 2.21%
Short Ratio 2.44
Perf Half Y 23.20%
Book/sh 11.51
P/B 0.96
EPS next Y -7.50%
ROA -10.02%
Short Interest 62.97M
Perf Year -46.40%
Cash/sh 1.38
P/C 8.06
EPS next 5Y -16.28%
ROE -60.05%
52W Range 8.08 - 22.05
Perf YTD 18.97%
Dividend Est. 0.83 (7.46% )
P/FCF -
EPS past 5Y -
ROI -23.36%
52W High -49.66%
Beta 0.66
Dividend TTM 0.75 (6.76% )
Quick Ratio 0.30
Sales past 5Y 1.77%
Gross Margin 16.00%
52W Low 37.38%
ATR (14) 0.38
Dividend Ex-Date Nov 18, 2024
Current Ratio 0.64
EPS Y/Y TTM -1637.59%
Oper. Margin 1.04%
RSI (14) 53.06
Volatility 0.80% 3.48%
Employees 312000
Debt/Eq 3.09
Sales Y/Y TTM 5.62%
Profit Margin -5.87%
Recom 2.82
Target Price 11.53
Option/Short Yes / Yes
LT Debt/Eq 2.80
EPS Q/Q -295.36%
Payout -
Rel Volume 1.44
Prev Close 11.12
Sales Surprise 5.50%
EPS Surprise 34.78%
Sales Q/Q 7.50%
Earnings Jan 10 BMO
Avg Volume 25.79M
Price 11.10
SMA20 0.46%
SMA50 1.54%
SMA200 5.02%
Trades
Volume 37,247,957
Change -0.18%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-28-25 Downgrade
Deutsche Bank
Hold → Sell
$11 → $9
Feb-26-24 Initiated
Leerink Partners
Market Perform
$23
Feb-20-24 Downgrade
HSBC Securities
Hold → Reduce
Jan-03-24 Initiated
Barclays
Underweight
$21
Dec-22-23 Initiated
HSBC Securities
Hold
$27
Oct-23-23 Upgrade
JP Morgan
Neutral → Overweight
$27 → $30
Jul-03-23 Reiterated
Morgan Stanley
Underweight
$37 → $27
Jun-28-23 Downgrade
Deutsche Bank
Buy → Hold
$46 → $34
Feb-23-23 Initiated
Loop Capital
Buy
$45
Nov-23-22 Resumed
Morgan Stanley
Underweight
$39
Nov-22-22 Upgrade
Cowen
Market Perform → Outperform
$43 → $54
Nov-18-22 Upgrade
JP Morgan
Neutral → Overweight
$42
Nov-11-22 Upgrade
Deutsche Bank
Hold → Buy
Apr-01-22 Downgrade
Robert W. Baird
Outperform → Neutral
$70 → $51
Dec-16-21 Downgrade
Morgan Stanley
Equal-Weight → Underweight
$56 → $49
Mar-25-21 Reiterated
Deutsche Bank
Hold
$49 → $55
Jan-11-21 Upgrade
Robert W. Baird
Neutral → Outperform
$55
Jan-11-21 Upgrade
Guggenheim
Neutral → Buy
$55
Jan-08-21 Resumed
Credit Suisse
Neutral
$42
Apr-06-20 Upgrade
UBS
Sell → Neutral
$49 → $44
Show Previous Ratings
Today 05:25PM
01:37PM
12:12PM
08:11AM
Mar-20-25 10:00AM
09:40AM
Loading…
09:40AM
07:45AM
07:38AM
Mar-18-25 05:50PM
09:43AM
08:20AM
01:15AM
Mar-15-25 07:00AM
Mar-13-25 10:35AM
Mar-12-25 04:23PM
02:26PM
Loading…
02:26PM
10:53AM
Mar-11-25 05:45PM
Mar-10-25 05:00AM
05:00AM
Mar-08-25 03:00PM
Mar-07-25 05:20PM
(The Wall Street Journal) +7.45%
04:31PM
04:05PM
04:05PM
03:50PM
02:52PM
12:13PM
11:54AM
11:53AM
11:17AM
Loading…
11:17AM
11:03AM
11:00AM
(The Wall Street Journal)
10:27AM
(The Wall Street Journal)
09:44AM
09:40AM
09:27AM
09:12AM
07:38AM
06:54AM
06:11AM
05:35AM
05:11AM
Mar-06-25 09:03PM
08:39PM
06:57PM
06:19PM
06:15PM
06:10PM
06:00PM
05:54PM
05:52PM
(Associated Press Finance)
05:37PM
05:33PM
05:33PM
05:15PM
05:15PM
05:00PM
(The Wall Street Journal)
08:30AM
Mar-05-25 05:45PM
03:26PM
08:00AM
Mar-04-25 09:03PM
06:40PM
05:05PM
04:57PM
04:23PM
04:21PM
03:04PM
02:53PM
02:24PM
02:17PM
12:59PM
12:07PM
10:34AM
09:53AM
09:40AM
08:53AM
08:08AM
07:12AM
05:26AM
Mar-03-25 07:48PM
(The Wall Street Journal)
Mar-01-25 04:37PM
Feb-28-25 04:26PM
03:32PM
12:52PM
12:47PM
10:42AM
10:18AM
09:38AM
Feb-27-25 05:45PM
05:07PM
04:16PM
11:51AM
11:00AM
09:24AM
09:08AM
08:35AM
Feb-26-25 07:17AM
02:37AM
(Thomson Reuters StreetEvents)
Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walgreens Boots Alliance, Inc. Former 10% owner Feb 18 '25 Sale 21.16 12,000,000 253,920,000 11,239,996 Feb 20 04:30 PM Walgreens Boots Alliance, Inc. 10% Owner Feb 06 '25 Sale 244.51 1,286,376 314,531,796 12,570,000 Feb 10 07:35 PM Walgreens Boots Alliance Holdi Affiliate Feb 06 '25 Proposed Sale 246.13 1,081,885 266,284,355 Feb 06 07:55 PM Walgreens Boots Alliance, Inc. 10% Owner Sep 11 '24 Sale 11.13 11,619,998 129,330,578 23,239,996 Sep 13 07:04 PM Walgreens Boots Alliance, Inc. 10% Owner Aug 01 '24 Sale 240.56 4,438,171 1,067,646,416 19,980,000 Aug 05 06:44 PM Walgreens Boots Alliance Holdi Affiliate Aug 01 '24 Proposed Sale 244.46 3,398,929 830,902,183 Aug 01 08:56 PM Walgreens Boots Alliance, Inc. 10% Owner May 22 '24 Sale 215.12 1,859,390 400,000,158 24,418,171 May 24 04:05 PM Bhandari Inderpal S Director Apr 11 '24 Buy 18.05 3,000 54,150 3,000 Apr 15 05:45 PM Mahajan Manmohan EVP and Global CFO Apr 02 '24 Buy 19.38 6,000 116,280 166,969 Apr 02 06:40 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite